Source: Colloids and Surfaces B: Biointerfaces. Unidade: FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis. Colloids and Surfaces B: Biointerfaces, v. 193, p. 1-8 art. 111097, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111097. Acesso em: 16 jun. 2024.APA
Souza, A. de, Yukuyama, M. N., Barbosa, E. J., Monteiro, L. M., Faloppa, A. C. B., Calixto, L. A., et al. (2020). A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis. Colloids and Surfaces B: Biointerfaces, 193, 1-8 art. 111097. doi:10.1016/j.colsurfb.2020.111097NLM
Souza A de, Yukuyama MN, Barbosa EJ, Monteiro LM, Faloppa ACB, Calixto LA, Araujo GLB de, Fotaki N, Löbenberg R, Bou-Chacra NA. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 193 1-8 art. 111097.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111097Vancouver
Souza A de, Yukuyama MN, Barbosa EJ, Monteiro LM, Faloppa ACB, Calixto LA, Araujo GLB de, Fotaki N, Löbenberg R, Bou-Chacra NA. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 193 1-8 art. 111097.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111097